| Ionizable cationic lipid for rna delivery |
2023-3-08 |
2023-5-23 |
|
| Translatable molecules and synthesis thereof |
2022-12-27 |
2023-4-11 |
|
| Ionizable cationic lipids for rna delivery |
2022-11-10 |
2023-9-21 |
|
| Lipid formulations containing nucleic acids and methods of treatment for cystic … |
2022-11-03 |
2023-5-25 |
|
| Compositions and methods for treating phenylketonuria |
2022-9-15 |
2023-3-23 |
|
| Rna vaccines |
2022-7-29 |
2023-7-13 |
|
| Synthetic transfer rna with extended anticodon loop |
2022-7-29 |
2023-6-15 |
|
| Ionizable cationic lipids for rna delivery |
2022-5-05 |
2023-1-12 |
|
| Peptide-lipid conjugates |
2022-5-05 |
2022-12-22 |
|
| Lipid compositions comprising peptide-lipid conjugates |
2022-5-05 |
2022-11-24 |
|
| Asialoglycoprotein receptor mediated delivery of therapeutically active … |
2022-2-21 |
2022-4-01 |
|
| Compositions and methods for treating metabolic disorders |
2021-12-30 |
2022-7-07 |
|
| TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES (TALEN) TARGETING HBV |
2021-12-28 |
2022-6-30 |
|
| Method of making lipid-encapsulated rna nanoparticles |
2021-9-14 |
2021-10-31 |
|
| Lipid nanoparticle encapsulation of large RNAs |
2021-9-13 |
2023-7-25 |
|
| Methods for Lyophilizing Lipid Nanoparticles |
2021-8-13 |
2023-9-04 |
|
| Una oligomers for the treatment of polyglutamine diseases |
2021-6-17 |
2021-12-23 |
|
| Una oligomers for the treatment of polyglutamine diseases |
2021-6-17 |
2021-12-23 |
|
| Nucleic acids and methods of treatment for cystic fibrosis |
2021-4-30 |
2022-1-27 |
|
| Synthesis and structure of high potency rna therapeutics |
2021-4-23 |
2021-10-14 |
|
| Ionizable cationic lipid for rna delivery |
2021-3-29 |
2021-10-21 |
|
| Compositions and methods for inducing immune responses |
2021-3-09 |
2023-9-19 |
2023-9-19 |
| Compositions and methods for the treatment of ornithine transcarbamylase … |
2021-3-03 |
2022-10-06 |
|
| Method of synthesis of an ionizable cationic lipid |
2020-9-21 |
2021-1-07 |
|
| Improved in vitro transcription purification platform |
2020-6-17 |
2022-9-29 |
|
| Synthetic transfer rna with extended anticodon loop |
2020-4-09 |
2020-10-15 |
|
| Molecules and agents for treating hepatitis B virus |
2019-12-20 |
2023-6-27 |
2023-6-27 |
| Modified proteins and associated methods of treatment |
2019-12-06 |
2021-10-13 |
|
| Compositions and methods for treating ornithine transcarbamylase deficiency |
2019-12-05 |
2023-6-27 |
2023-6-27 |
| Abuse deterrent formulations of amphetamine |
2019-11-11 |
2020-3-19 |
|
| Trinucleotide mrna cap analogs |
2019-10-11 |
2020-2-06 |
|
| Compositions and agents against nonalcoholic steatohepatitis |
2019-8-08 |
2021-6-16 |
|
| Lipid particles for nucleic acid delivery |
2019-4-01 |
2020-6-18 |
|
| Compositions and agents against hepatitis b virus and uses thereof |
2018-8-30 |
2018-12-27 |
|
| UNA oligomers having reduced off-target effects in gene silencing |
2018-8-22 |
2020-6-16 |
2020-6-16 |
| Therapeutics for phenylketonuria |
2018-5-31 |
2021-2-24 |
|
| UNA oligomers for therapeutics with prolonged stability |
2018-4-13 |
2019-10-29 |
2019-10-29 |
| Nucleic acid vaccine composition comprising a lipid formulation, and method of … |
2018-3-30 |
2020-2-05 |
|
| Ionizable cationic lipid for rna delivery |
2018-3-21 |
2018-8-10 |
|
| Ionizable cationic lipid for RNA delivery |
2018-2-09 |
2019-3-12 |
2019-3-12 |
| Multiligand agent for drug delivery |
2018-1-22 |
2021-5-31 |
|
| Una oligomers and compositions for treating amyloidosis |
2018-1-20 |
2018-5-31 |
|
| Therapeutic oligomers for treating amyloidosis |
2017-12-31 |
2020-3-31 |
2020-3-31 |
| Messenger UNA molecules and uses thereof |
2017-11-07 |
2020-10-27 |
2020-10-27 |
| Aromatic ionizable cationic lipid |
2017-10-31 |
2018-2-22 |
|
| UNA oligomers and amidites for therapeutic agents |
2017-3-08 |
2017-8-17 |
|
| Lipid particles with cationic lipids for rna delivery |
2017-2-09 |
2017-6-01 |
|
| Allele selective gene editing and uses thereof |
2016-9-21 |
2019-9-25 |
|
| Una oligomeric agents for stimulating cystic fibrosis transmembrane conductance … |
2016-8-12 |
2017-2-16 |
|
| Mir-124 compositions for immune modulatory therapeutics |
2016-7-22 |
2017-2-02 |
|
| Therapeutic UNA oligomers and uses thereof |
2016-4-01 |
2019-12-31 |
2019-12-31 |
| Method for the treatment, alleviation of symptoms of, relieving, improving and … |
2016-3-18 |
2016-7-14 |
|
| Acyl-amino-LNA oligonucleotide and / or hydrocarbyl-amino-LNA oligonucleotide |
2016-2-15 |
2018-6-07 |
|
| Methods Of Treating Fragile X Syndrome And Related Disorders |
2015-8-05 |
2015-11-26 |
|
| Method for decreasing symptoms of alcohol consumption |
2015-4-03 |
2017-11-07 |
2017-11-07 |
| Transthyretin allele selective una oligomers for gene silencing |
2015-3-25 |
2015-10-29 |
|
| Una oligomers having reduced off-target effects in gene silencing |
2015-3-24 |
2023-9-26 |
2023-9-26 |
| Substituted pyridoxine-lactam carboxylate-salts |
2014-10-03 |
2015-1-22 |
|
| Methods of determining response to therapy |
2014-9-09 |
2016-3-24 |
|
| UNA amidites for therapeutic oligomers |
2013-12-19 |
2014-1-16 |
|
| Oligomeres una a effets hors cible reduits pour le silencage genetique |
2015-3-24 |
2023-9-26 |
2023-9-26 |